NYSE USD
Ginkgo Bioworks Holdings, Inc. (DNA)
7.60
+0.06
+(0.80%)
At close: April 23 at 4:00:02 PM EDT
7.55
-0.05
(-0.66%)
Pre-Market: 4:17:00 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 21,865 | 11 |
| Sales | 5,987 | 10 |
| Net Shares Purchased (Sold) | 15,878 | 21 |
| Total Insider Shares Held | 3.59M | -- |
| % Net Shares Purchased (Sold) | 0.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Mar 13, 2025 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 7.72 per share. | Direct | 6,103 | Mar 4, 2025 |
| COEN STEVEN P. Officer | Sale at price 7.72 per share. | Direct | 3,051 | Mar 4, 2025 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Mar 3, 2025 |
| COEN STEVEN P. Officer | -- | Direct | -- | Mar 3, 2025 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 13.44 per share. | Direct | 9,948 | Feb 4, 2025 |
| COEN STEVEN P. Officer | Sale at price 13.44 per share. | Direct | 4,934 | Feb 4, 2025 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Feb 3, 2025 |
| COEN STEVEN P. Officer | -- | Direct | -- | Feb 3, 2025 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 11.72 per share. | Direct | 7,558 | Jan 6, 2025 |
| COEN STEVEN P. Officer | Sale at price 11.72 per share. | Direct | 3,797 | Jan 6, 2025 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Jan 3, 2025 |
| COEN STEVEN P. Officer | -- | Direct | -- | Jan 3, 2025 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 9.64 per share. | Direct | 7,146 | Dec 4, 2024 |
| COEN STEVEN P. Officer | Sale at price 9.64 per share. | Direct | 3,183 | Dec 4, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Dec 3, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Dec 3, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 7.58 per share. | Direct | 10,015 | Nov 4, 2024 |
| COEN STEVEN P. Officer | Sale at price 7.58 per share. | Direct | 2,523 | Nov 4, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Nov 1, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Nov 1, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 8.35 per share. | Direct | 10,163 | Oct 4, 2024 |
| COEN STEVEN P. Officer | Sale at price 8.35 per share. | Direct | 2,555 | Oct 4, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Oct 3, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Oct 3, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 6.17 per share. | Direct | 7,085 | Sep 12, 2024 |
| COEN STEVEN P. Officer | Sale at price 6.17 per share. | Direct | 1,950 | Sep 12, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Sep 11, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Sep 11, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 0.29 per share. | Direct | 18,244 | Aug 2, 2024 |
| COEN STEVEN P. Officer | Sale at price 0.29 per share. | Direct | 5,018 | Aug 2, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Aug 1, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Aug 1, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 0.33 per share. | Direct | 16,027 | Jul 2, 2024 |
| COEN STEVEN P. Officer | Sale at price 0.33 per share. | Direct | 4,408 | Jul 2, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | Jul 1, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | Jul 1, 2024 |
| SLOAN HARRY EVANS Director | -- | Direct | -- | Jun 12, 2024 |
| DEKKERS MARIJN E Director | -- | Direct | -- | Jun 12, 2024 |
| HENRY CHRISTIAN O Director | -- | Direct | -- | Jun 12, 2024 |
| BELLDEGRUN ARIE S Director | -- | Direct | -- | Jun 12, 2024 |
| KEWALRAMANI RESHMA Director | -- | Direct | -- | Jun 12, 2024 |
| HANNAN KATHY HOPINKAH Director | -- | Direct | -- | Jun 12, 2024 |
| SANKAR SHYAM Director | -- | Direct | -- | Jun 12, 2024 |
| DMYTRUK MARK E Chief Financial Officer | Sale at price 0.55 per share. | Direct | 26,827 | Jun 3, 2024 |
| COEN STEVEN P. Officer | Sale at price 0.55 per share. | Direct | 7,379 | Jun 3, 2024 |
| DMYTRUK MARK E Chief Financial Officer | -- | Direct | -- | May 31, 2024 |
| COEN STEVEN P. Officer | -- | Direct | -- | May 31, 2024 |
| DEKKERS MARIJN E Director | Sale at price 0.83 per share. | Indirect | 220,030 | May 16, 2024 |
| SANKAR SHYAM Director | Purchase at price 0.82 per share. | Direct | 514,750 | May 15, 2024 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%
RXRX Recursion Pharmaceuticals, Inc.
5.58
-0.89%
EDIT Editas Medicine, Inc.
1.5600
0.00%
BEAM Beam Therapeutics Inc.
19.87
+3.87%
CRSP CRISPR Therapeutics AG
38.54
-1.76%
PRME Prime Medicine, Inc.
1.7800
+5.33%
VERV Verve Therapeutics, Inc.
5.47
+4.19%
BLUE bluebird bio, Inc.
4.0900
-5.76%
ABSI Absci Corporation
3.1900
-0.62%
CRBU Caribou Biosciences, Inc.
0.8423
+0.79%